In just the last few years, Hong Kong and China have established themselves as essential hubs for growth and innovation in the biotechnology space. With a robust and eager domestic market, a globally prominent financial centre, an openness for utilsing data collection and artificial intelligence in the healthcare space, and government sponsored funding schemes, opportunities in this sector are vast. What are the latest trends in biotech in Asia? What are the key factors contributing to biotech growth in Hong Kong and China and what are the latest investment trends? How can these technologies aid in higher quality medical care and efficiency? How are government initiatives aiding in the growth of biotech? How are these technologies working to fight viral outbreaks like Covid-19?